Elena Ridloff is CFO & VP at ACADIA PHARMACEUTICALS INC (ACAD). They have made 7 open-market trades across 2 companies since 2019, most recently 2026-09-17.
CIK 0001772518
1 open-market purchase totalling $50K since 2020, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KYMR | SELL · 10b5-1 | 2026-05-11 | 2026-05-11 | $87.00 | $261K | -3.8% | -6.5% | +29.6% |
| KYMR | SELL · 10b5-1 | 2026-03-31 | 2026-04-01 | $85.39 | $1.0M | +8.6% | -2.5% | +38.6% |
| SION | SELL · 10b5-1 | 2025-08-29 | 2025-09-03 | $25.08 | $462K | -10.5% | +20.4% | +56.5% |
| SION | SELL · 10b5-1 | 2025-08-26 | 2025-08-28 | $25.75 | $1.1M | -7.4% | +16.5% | +72.8% |
| SION | SELL · 10b5-1 | 2025-08-19 | 2025-08-21 | $21.41 | $1.9M | +2.9% | +8.5% | +61.0% |
| KYMR | SELL · 10b5-1 | 2025-06-11 | 2025-06-11 | $50.00 | $225K | -2.0% | -7.5% | -9.6% |
| KYMR | SELL · 10b5-1 | 2025-06-03 | 2025-06-03 | $46.10 | $553K | +7.4% | +2.4% | -7.0% |
| ACAD | SELL | 2021-04-30 | 2021-04-30 | $20.33 | $21K | +6.3% | +8.8% | +8.5% |
| ACAD | SELL | 2021-02-04 | 2021-02-08 | $50.61 | $208K | +1.3% | -47.3% | -58.8% |
| ACAD | SELL | 2021-01-06 | 2021-01-08 | $53.34 | $108K | -2.2% | -3.6% | -61.1% |
| KRON | BUY | 2020-10-14 | 2020-10-16 | $19.00 | $50K | -7.0% | -5.8% | -1.4% |
| ACAD | SELL | 2020-04-29 | 2020-05-01 | $50.60 | $559K | +3.4% | +9.8% | -4.6% |
| ACAD | SELL | 2019-12-09 | 2019-12-11 | $49.66 | $1.8M | -1.1% | +0.4% | -9.0% |
| ACAD | SELL | 2019-12-09 | 2019-12-11 | $49.49 | $3.0M | -1.1% | +0.4% | -9.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.